Two largest organ transplant societies join forces to tackle problem of traditional and exotic infections in thoracic transplantation
Complications from infectious diseases, such as HIV and West Nile virus in heart and lung transplant patients, is the focus of a joint symposium at the International Society for Heart and Lung Transplantation (ISHLT) 24th Annual Meeting held in San Francisco.
When demand for organs continually outstrips supply, offering transplants to patients with infectious diseases, such as HIV, remains controversial. For those needing heart and lung transplants, it’s not only controversial but somewhat uncharted territory. Only in the last few years have organ transplants even been offered to HIV-positive patients, much less performed; and most of the procedures have been liver and kidney transplants.
In addition to traditional viral infections, such as herpes, hepatitis C and influenza, "exotic" infections like SARS and West Nile virus are becoming a major problem for transplant recipients. These infections may have direct effects contributing to morbidity and mortality, as well as indirect effects resulting in organ dysfunction and loss.
Atul Humar, M.D. from the University of Toronto, Canada, is presenting SARS and West Nile virus as emerging infectious diseases in transplantation. Although most infections in the general population are asymptomatic, little is known about the consequences of infection in transplant recipients.
"Efforts aimed at improving our understanding of the diagnosis, natural history, prevention and treatment of these infections will lead to improved transplant organ and patient survival," said Dr. Humar.
About ISHLT The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit organization dedicated to the advancement of the science and treatment of end-stage heart and lung diseases. Created in 1981 at a gathering of about 15 cardiologists and cardiac surgeons, the Society now includes more than 2,200 members from 45-plus countries, representing a variety of disciplines involved in the management and treatment of end-stage heart and lung disease.
ISHLT maintains two databases. The International Heart and Lung Transplant Registry is a one-of-a-kind registry that has been collecting data since 1983 from 223 hospitals from 18 countries. The ISHLT Mechanical Circulatory Device (MCSD) database has been collecting data since 2002 with the aim of identifying patient populations who may benefit from MCSD implantation; generating predictive models for outcomes; and assessing the mechanical and biological reliability of current and future devices.
Kelly Goff | EurekAlert!
New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center
Pain: Perception and motor impulses arise in the brain independently of one another
12.12.2018 | Technische Universität München
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
13.12.2018 | Physics and Astronomy
13.12.2018 | Earth Sciences
13.12.2018 | Life Sciences